Additionally, pre-mRNA processing factor 19 (PRP19) promotes ESCC progression by stabilizing SREBP1 mRNA in an m6A-dependent manner, thereby reprogramming fatty acid metabolism, this indicates PRP19 as a potential prognostic biomarker and therapeutic target (Zhang et al., 2023). Here, SREBF1 is linked to esophageal squamous cell carcinoma.